The hope is that renal denervation will solve not only hypertension-related complications but also the various problems associated with antihypertensive drugs that have a negative impact on quality of ...

A new meta-analysis of six sham-controlled studies of renal sympathetic denervation (RSD) has shown a significant reduction in blood pressure with the technique. "After the SYMPLICITY HTN-3 trial, ...

PARIS, France—With renal denervation on the cusp of gaining a place in clinical practice for the treatment of hypertension, researchers are looking more closely at other conditions associated with ...

The treatment of resistant hypertension has received a boost with the recent US Food and Drug Administration (FDA) approval of a completely new therapeutic approach that reduces activity in the ...

Please provide your email address to receive an email when new articles are posted on . Data show renal denervation safely lowers BP, but some question the durability of effect. Experts continue to ...

Credit: Medtronic. The Simplicity Spyral RDN system is designed to lower BP by delivering radiofrequency energy through the wall of the renal artery to denervate the kidney from sympathetic nerve ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

Ablating the sympathetic nerves in accessory renal arteries might help enhance the blood pressure-lowering effects of renal denervation, a study of tissues from human cadavers suggests. Though ...

Please provide your email address to receive an email when new articles are posted on . Two FDA-approved renal denervation systems are now commercially available in the U.S. The devices are approved ...

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. We have a new way of making ...

Credit: Recor Medical. The approval was based on data from the RADIANCE II trial which included patient with mild to moderate hypertension who were adequately controlled with medications. The Food and ...